Prot #YH001/KN035SAR101: A Phase 1/2 Study of YH001 In Combination With Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma

Project: Research project

Project Details

StatusActive
Effective start/end date2/17/23 → 2/17/26

Funding

  • TRACON Pharmaceuticals, Inc. (Prot #YH001/KN035SAR101)